Shozo Ohsumi

Summary

Affiliation: National Shikoku Cancer Center
Country: Japan

Publications

  1. ncbi request reprint Factors affecting enrollment in a randomized controlled trial for Japanese metastatic breast cancer patients (SELECT BC-FEEL)--a prospective study
    Shozo Ohsumi
    Department of Breast Oncology, NHO Shikoku Cancer Center, Matsuyama, Ehime
    Jpn J Clin Oncol 44:696-701. 2014
  2. doi request reprint Breast biopsy for mammographically detected nonpalpable lesions using a vacuum-assisted biopsy device (Mammotome) and upright-type stereotactic mammography unit without a digital imaging system: experience of 500 biopsies
    Shozo Ohsumi
    Department of Breast Oncology, The National Hospital Organization Shikoku Cancer Center, 160 Kou, Minami umemoto machi, Matsuyama, 791 0280, Japan
    Breast Cancer 21:123-7. 2014
  3. ncbi request reprint Current status and future perspectives of patient-reported outcome research in clinical trials for patients with breast cancer in Japan
    Shozo Ohsumi
    Department of Breast Oncology, The National Hospital Organization Shikoku Cancer Center, 160 Kou, Minami umemoto machi, Matsuyama, 791 0280, Japan
    Breast Cancer 20:296-301. 2013
  4. doi request reprint Subjective and objective assessment of edema during adjuvant chemotherapy for breast cancer using taxane-containing regimens in a randomized controlled trial: The National Surgical Adjuvant Study of Breast Cancer 02
    Shozo Ohsumi
    Department of Breast Oncology, NHO Shikoku Cancer Center, Matsuyama, Japan
    Oncology 82:131-8. 2012
  5. ncbi request reprint Breast biopsy for mammographically detected non-palpable lesions using a vacuum-assisted biopsy device (Mammotome) and an upright-type stereotactic mammography unit
    S Ohsumi
    Department of Surgery, National Shikoku Cancer Center, 13 Hori no uchi, Matsuyama, Ehime 790 0007, Japan
    Jpn J Clin Oncol 31:527-31. 2001
  6. ncbi request reprint Quality of life of breast cancer patients and types of surgery for breast cancer--current status and unresolved issues
    Shozo Ohsumi
    Department of Breast Oncology, National Hospital Organization Shikoku Cancer Center, Matsuyama, Japan
    Breast Cancer 14:66-73. 2007
  7. ncbi request reprint Factors associated with health-related quality-of-life in breast cancer survivors: influence of the type of surgery
    Shozo Ohsumi
    Department of Breast Oncology, The National Hospital Organization Shikoku Cancer Center, Kou 160, Minami umemoto machi, Matsuyama 791 0280, Japan
    Jpn J Clin Oncol 39:491-6. 2009
  8. doi request reprint Detection of isolated ipsilateral regional lymph node recurrences by F18-fluorodeoxyglucose positron emission tomography-CT in follow-up of postoperative breast cancer patients
    Shozo Ohsumi
    Department of Breast Oncology, The National Hospital Organization Shikoku Cancer Center, Matsuyama, 791 0280, Japan
    Breast Cancer Res Treat 130:267-72. 2011
  9. ncbi request reprint Techniques for the neurological examination of taxane-induced neuropathy
    Shozo Ohsumi
    Department of Surgery, National Shikoku Cancer Center, 13 Hori no uchi, Matsuyama, Ehime 790 0007, Japan
    Breast Cancer 11:86-91. 2004
  10. ncbi request reprint Long-term results of breast-conserving treatment for early-stage breast cancer in Japanese women from multicenter investigation
    Shozo Ohsumi
    National Shikoku Cancer Center, Matsuyama, Japan
    Jpn J Clin Oncol 33:61-7. 2003

Detail Information

Publications55

  1. ncbi request reprint Factors affecting enrollment in a randomized controlled trial for Japanese metastatic breast cancer patients (SELECT BC-FEEL)--a prospective study
    Shozo Ohsumi
    Department of Breast Oncology, NHO Shikoku Cancer Center, Matsuyama, Ehime
    Jpn J Clin Oncol 44:696-701. 2014
    ..We are using a self-administered questionnaire that we have developed to collect information regarding patients' characteristics and attitude to clinical trials. ..
  2. doi request reprint Breast biopsy for mammographically detected nonpalpable lesions using a vacuum-assisted biopsy device (Mammotome) and upright-type stereotactic mammography unit without a digital imaging system: experience of 500 biopsies
    Shozo Ohsumi
    Department of Breast Oncology, The National Hospital Organization Shikoku Cancer Center, 160 Kou, Minami umemoto machi, Matsuyama, 791 0280, Japan
    Breast Cancer 21:123-7. 2014
    ..We have used an upright-type stereotactic mammography unit without a digital imaging system instead of the prone table...
  3. ncbi request reprint Current status and future perspectives of patient-reported outcome research in clinical trials for patients with breast cancer in Japan
    Shozo Ohsumi
    Department of Breast Oncology, The National Hospital Organization Shikoku Cancer Center, 160 Kou, Minami umemoto machi, Matsuyama, 791 0280, Japan
    Breast Cancer 20:296-301. 2013
    ..Here, we review the results of PRO research in RCTs conducted in Japan and examine future perspectives in this field. ..
  4. doi request reprint Subjective and objective assessment of edema during adjuvant chemotherapy for breast cancer using taxane-containing regimens in a randomized controlled trial: The National Surgical Adjuvant Study of Breast Cancer 02
    Shozo Ohsumi
    Department of Breast Oncology, NHO Shikoku Cancer Center, Matsuyama, Japan
    Oncology 82:131-8. 2012
    ..To elucidate the time course of taxane-induced edema which may affect the patients' quality of life (QOL)...
  5. ncbi request reprint Breast biopsy for mammographically detected non-palpable lesions using a vacuum-assisted biopsy device (Mammotome) and an upright-type stereotactic mammography unit
    S Ohsumi
    Department of Surgery, National Shikoku Cancer Center, 13 Hori no uchi, Matsuyama, Ehime 790 0007, Japan
    Jpn J Clin Oncol 31:527-31. 2001
    ..It is crucial to develop a useful minimally invasive biopsy method which can be applied without difficulty...
  6. ncbi request reprint Quality of life of breast cancer patients and types of surgery for breast cancer--current status and unresolved issues
    Shozo Ohsumi
    Department of Breast Oncology, National Hospital Organization Shikoku Cancer Center, Matsuyama, Japan
    Breast Cancer 14:66-73. 2007
    ..Viewpoints and issues on surgical treatment-related QOL are discussed...
  7. ncbi request reprint Factors associated with health-related quality-of-life in breast cancer survivors: influence of the type of surgery
    Shozo Ohsumi
    Department of Breast Oncology, The National Hospital Organization Shikoku Cancer Center, Kou 160, Minami umemoto machi, Matsuyama 791 0280, Japan
    Jpn J Clin Oncol 39:491-6. 2009
    ..Factors associated with QOL in long-term BC survivors were also identified...
  8. doi request reprint Detection of isolated ipsilateral regional lymph node recurrences by F18-fluorodeoxyglucose positron emission tomography-CT in follow-up of postoperative breast cancer patients
    Shozo Ohsumi
    Department of Breast Oncology, The National Hospital Organization Shikoku Cancer Center, Matsuyama, 791 0280, Japan
    Breast Cancer Res Treat 130:267-72. 2011
    ....
  9. ncbi request reprint Techniques for the neurological examination of taxane-induced neuropathy
    Shozo Ohsumi
    Department of Surgery, National Shikoku Cancer Center, 13 Hori no uchi, Matsuyama, Ehime 790 0007, Japan
    Breast Cancer 11:86-91. 2004
    ....
  10. ncbi request reprint Long-term results of breast-conserving treatment for early-stage breast cancer in Japanese women from multicenter investigation
    Shozo Ohsumi
    National Shikoku Cancer Center, Matsuyama, Japan
    Jpn J Clin Oncol 33:61-7. 2003
    ..Although many clinical data regarding breast-conserving treatment have already been reported from European and North American countries, few clinical data with long-term follow-up have been reported from Japan...
  11. ncbi request reprint Breast-conserving therapy consisting of wide excision, axillary dissection, and radiotherapy for early-stage breast cancer: the experience of the National Shikoku Cancer Center
    Shozo Ohsumi
    Department of Surgery, The National Shikoku Cancer Center, Matsuyama, Japan
    Biomed Pharmacother 56:196s-200s. 2002
    ..In conclusion, BCT consisting of wide excision, axillary dissection and radiotherapy is useful and effective for patients with early-stage breast cancer...
  12. doi request reprint Health-related quality of life and psychological distress of breast cancer patients after surgery during a phase III randomized trial comparing continuation of tamoxifen with switching to anastrozole after adjuvant tamoxifen for 1-4 years: N-SAS BC 03
    Shozo Ohsumi
    Department of Breast Oncology, National Hospital Organization Shikoku Cancer Center, 160 Kou, Minami umemoto machi, Matsuyama, Ehime 791 0280, Japan
    Breast Cancer Res Treat 127:143-52. 2011
    ..Continuation of tamoxifen treatment after adjuvant tamoxifen for 1-4 years may provide Japanese breast cancer patients with better HRQOL than by switching to anastrozole...
  13. ncbi request reprint Prognostic value of thermographical findings in patients with primary breast cancer
    Shozo Ohsumi
    Department of Surgery, National Shikoku Cancer Center, Matsuyama, Ehime, Japan
    Breast Cancer Res Treat 74:213-20. 2002
    ..0251). However, AT did not have prognostic impact on the node negative patients. AT might be a useful prognostic factor in node positive breast cancer, especially in patients who plan to be treated with preoperative systemic therapy...
  14. ncbi request reprint Ipsilateral breast tumor recurrence (IBTR) after breast-conserving treatment for early breast cancer: risk factors and impact on distant metastases
    Yoshifumi Komoike
    Department of Surgery, Osaka Medical Center for Cancer and Cardiovascular Diseases, Osaka, Japan
    Cancer 106:35-41. 2006
    ..The purpose of this study was to clarify risk factors of IBTR and the impact of IBTR on development of distant metastases in this ethnic group...
  15. doi request reprint Volume-based parameters of 18F-fluorodeoxyglucose positron emission tomography/computed tomography improve disease recurrence prediction in postmastectomy breast cancer patients with 1 to 3 positive axillary lymph nodes
    Naomi Nakajima
    Department of Radiation Oncology, National Hospital Organization Shikoku Cancer Center, Ehime, Japan Department of Radiology, Ehime University, Ehime, Japan Electronic address
    Int J Radiat Oncol Biol Phys 87:738-46. 2013
    ....
  16. doi request reprint Impact of aggregate of risk factors for isolated locoregional failure in breast cancer patients treated with mastectomy without radiotherapy
    Yasushi Hamamoto
    Department of Radiation Oncology, National Hospital Organization Shikoku Cancer Center, Kou 160, Minamiumemoto Machi, Matsuyama, Ehime, Japan
    Breast Cancer 20:247-53. 2013
    ..The impact of aggregate of risk factors on isolated locoregional failure after mastectomy without radiotherapy was assessed...
  17. doi request reprint Two cases of occult breast cancer in which PET-CT was helpful in identifying primary tumors
    Daisuke Takabatake
    Department of Breast Oncology, National Hospital Organization, National Shikoku Cancer Center, 160 Ko, Minamiumemoto, Matsuyama, Ehime, 791 0280, Japan
    Breast Cancer 15:181-4. 2008
    ..Pathologic diagnosis indicated invasive cancer. PET-CT is a helpful option for the diagnosis of occult breast cancer with primary sites that conventional imaging studies have difficulty identifying...
  18. doi request reprint Efficacy and safety of S-1 in patients with metastatic breast cancer: retrospective review in a single institution
    Fumikata Hara
    Department of Breast Oncology, National Hospital Organization Shikoku Cancer Center, Matsuyama, Japan
    Oncology 79:273-7. 2010
    ..The current retrospective study was conducted to find whether S-1, an orally administered 5-FU agent, can produce a therapeutic result in patients with recurrent metastatic breast cancer while maintaining their QOL...
  19. doi request reprint Prospective assessment of chemotherapy-induced peripheral neuropathy due to weekly paclitaxel in patients with advanced or metastatic breast cancer (CSP-HOR 02 study)
    Katsumasa Kuroi
    Department of Surgery, Division of Clinical Trials and Research, Tokyo Metropolitan Cancer and Infectious Disease Center Komagome Hospital, 3 18 22 Honkomagome, Bunkyo ku, Tokyo 113 8677, Japan
    Support Care Cancer 17:1071-80. 2009
    ....
  20. ncbi request reprint False-positive (18)F-fluorodeoxyglucose positron emission tomography/computed tomography caused by incidental injury in a bulky intracystic carcinoma of the breast
    Sachiko Kiyoto
    Department of Breast Oncology, Shikoku Cancer Center, 160 Minamiumemoto, Matsuyama, 791 0280, Japan
    Jpn J Radiol 28:305-8. 2010
    ..In conclusion, the coexisting foreign body inflammation was responsible for a false-positive (18)F-FDG-PET/CT scan in the current case...
  21. ncbi request reprint Two cases with long-term disease-free survival after resection and radiotherapy for solitary brain metastasis from breast cancer with extensive nodal metastases
    Shinsuke Saisho
    Department of Surgery, Unnan Municipal General Hospital, 96 1 Iida, Daito chou, Unnan city, Shimane 699 1221, Japan
    Breast Cancer 12:221-5. 2005
    ....
  22. ncbi request reprint A questionnaire survey of physicians' perspectives regarding the assessment of chemotherapy-induced peripheral neuropathy in patients with breast cancer
    Katsumasa Kuroi
    Division of Clinical Trials and Research, Department of Surgery, Tokyo Metropolitan Cancer and Infectious Disease Center Komagome Hospital, Tokyo, Japan
    Jpn J Clin Oncol 38:748-54. 2008
    ..The aim of this study was to evaluate the physicians' perspectives regarding the utility and diagnostic value of PNQ...
  23. doi request reprint Examination of the use of Exemestane in patients with metastatic breast cancer
    Seiki Takashima
    Department of Breast Oncology, National Hospital Organization Shikoku Cancer Center, 160 Ko, Minamiumemoto cho, Matsuyama, Ehime, 791 0280, Japan
    Breast Cancer 18:189-94. 2011
    ..Aromatase inhibitors (AIs) are becoming the first choice for postmenopausal patients with metastatic breast cancer. AIs are divided into non-steroidal and steroidal agents...
  24. ncbi request reprint Analysis of ipsilateral breast tumor recurrences after breast-conserving treatment based on the classification of true recurrences and new primary tumors
    Yoshifumi Komoike
    Department of Surgery, Osaka Medical Center for Cancer and Cardiovascular Diseases, 1 3 3 Nakamichi, Higashinari ku, Osaka 537 8511, Japan
    Breast Cancer 12:104-11. 2005
    ..The aim of this study is to clarify the biological difference between TR and NP, and to show the clinical significance of classifying IBTR into these two types of recurrence...
  25. ncbi request reprint S-1 (TS-1) maintained complete response for approximately 10 years in a case of metastatic breast cancer
    Naruto Taira
    Department of Surgery, National Hospital Organization, National Shikoku Cancer Center, Matsuyama City, Ehime, Japan
    Breast Cancer 13:220-4. 2006
    ..S-1 could be a valuable agent for breast cancer treatments, since it showed clinical efficacy and mild toxicity, and can be given orally...
  26. ncbi request reprint Non-palpable ductal carcinoma in situ (DCIS) with microinvasion arising in a radial scar presenting with spiculation alone on mammograms: a case report
    Atsushi Okita
    Department of Surgery, National Hospital Organization, Shikoku Cancer Center Horinouchi 13, Matsuyama, 790 0007, Japan
    Breast Cancer 13:107-11. 2006
    ..We discuss the characteristics of a radial scar and its relationship to breast cancer based on our experience and a review of the literature...
  27. doi request reprint Identification of candidates for postmastectomy radiotherapy in patients with pT3N0M0 breast cancer
    Yasushi Hamamoto
    Department of Radiation Oncology, National Hospital Organization Shikoku Cancer Center, Kou 160, Minamiumemoto Machi, Matsuyama, Ehime, Japan
    Breast Cancer 20:218-22. 2013
    ..To identify the candidates for PMRT in this subset, we investigated failure patterns, and searched for risk factors for isolated locoregional failure in pT3N0M0 breast cancer after mastectomy without PMRT...
  28. ncbi request reprint [Efficacy of vinorelbine monotherapy in advanced and metastatic breast cancer]
    Hiroshi Suehisa
    Department of Surgery, National Hospital Organization Shikoku Cancer Center
    Gan To Kagaku Ryoho 35:1709-12. 2008
    ..The major toxicity was grade 3 or 4 neutropenia(15.7%), and superficial phlebitis(7.8%). Vinorelbine will be a standard treatment agent for patients pretreated with anthracyclines and taxanes...
  29. ncbi request reprint Effect of mechanical closure of dead space on seroma formation after breast surgery
    Katsumasa Kuroi
    Department of Surgery, Breast Oncology, Medical Corporation Nyuwakai Oikawa Hospital, 2 21 16 Hirao, Chuo Ku, Fukuoka 810 0014, Japan
    Breast Cancer 13:260-5. 2006
    ..However, previous studies have often been small in scale and poor in quality. Further studies should examine the effect of this technique on quality of life, cosmesis, and medical economics...
  30. ncbi request reprint Synchronous liver metastases of intracystic papillary carcinoma with invasion of the breast
    Riki Okita
    Department of Surgery, National Hospital Organization Shikoku Cancer Center, Japan
    Breast Cancer 12:327-30. 2005
    ..The potential of distant metastasis in IPC with invasion and the difficulty of evaluating invasive foci should be recognized. Careful evaluation of distant metastases is recommended...
  31. doi request reprint Suspicious calcifications in benign breast lesions: a radio-pathologic correlation
    Rieko Nishimura
    Department of Clinical Laboratory, National Hospital Organization Shikoku Cancer Center, 160 Kou, Minamiumemoto Machi, Matsuyama, Ehime, Japan
    Breast Cancer 18:33-6. 2011
    ..It is thus important to examine which pathologically benign lesions were read as suspicious on MMG to reduce the number of biopsies in the case of benign breast lesions...
  32. ncbi request reprint A case of metastatic breast cancer with HER2 gene amplification that responded completely to single agent trastuzumab
    Yasuhiro Tsutani
    Department of Surgery, National Hospital Organization Shikoku Cancer Center, 2 3 10 Kitashinchi, Saka cho, Aki gun, Hiroshima, Japan
    Breast Cancer 13:374-7. 2006
    ..CT showed no lung tumors. During the trastuzumab treatment, no adverse effect was observed. Her performance status improved to zero, and she is alive and free from the disease 24 months after the disappearance of the tumor...
  33. ncbi request reprint Invasive cribriform carcinoma with extensive microcalcifications in the male breast
    Rieko Nishimura
    Department of Clinical Laboratory, National Hospital Organization Shikoku Cancer Center, Horinouchi 13, Matsuyama, Ehime 790 0007, Japan
    Breast Cancer 12:145-8. 2005
    ..The patient is presently free from local recurrence or metastasis 7 months after undergoing surgery...
  34. ncbi request reprint Epidermal inclusion cyst of the breast
    Naruto Taira
    Department of Surgery, National Hospital Organization, National Shikoku Cancer Center, Ehime, 791 1288, Japan
    Breast Cancer 14:434-7. 2007
    ..A phyllodes tumor or a giant fibroadenoma was suspected on the basis of clinical and imaging findings, but the resected specimen revealed an epidermal inclusion cyst...
  35. ncbi request reprint Nodular pseudoangiomatous stromal hyperplasia of mammary stroma in a case showing rapid tumor growth
    Naruto Taira
    Department of Surgery, National Hospital Organization Shikoku Cancer Center, Matsuyama City, Ehime, Japan
    Breast Cancer 12:331-6. 2005
    ..Immunohistochemical staining showed that endothelial cells lining true blood vessels were positive for Factor VIII-related antigen, but the spindle cells were negative for Factor VIII. Pseudoangiomatous stromal hyperplasia was diagnosed...
  36. doi request reprint Are there high-risk subgroups for isolated locoregional failure in patients who had T1/2 breast cancer with one to three positive lymph nodes and received mastectomy without radiotherapy?
    Yasushi Hamamoto
    Department of Radiation Oncology, National Hospital Organization Shikoku Cancer Center, Kou 160, Minamiumemoto Machi, Matsuyama, Ehime, 791 0280, Japan
    Breast Cancer 21:177-82. 2014
    ..To define the factors associated with increased risk of isolated locoregional failure that may justify postmastectomy radiotherapy in patients with T1/2 breast cancer and 1-3 positive lymph nodes...
  37. ncbi request reprint Pathophysiology of seroma in breast cancer
    Katsumasa Kuroi
    Department of Surgery, Showa University Toyosu Hospital, Koutou ku, Tokyo 135 8577, Japan
    Breast Cancer 12:288-93. 2005
    ..Seroma is the most common complication of mastectomy. The aim of this systematic review is to clarify the pathophysiology of seroma...
  38. ncbi request reprint [Genetic counseling and practice of hereditary cancers at Shikoku Cancer Center]
    Keika Kaneko
    Familial Tumor Counseling Service, National Hospital Organization Shikoku Cancer Center, Matsuyama, Ehime, Japan
    Gan To Kagaku Ryoho 40:139-42. 2013
    ..Here we present the framework of our practice in treating hereditary cancers. We discuss appropriate goals and future perspectives in the field of hereditary cancer in Japan...
  39. ncbi request reprint Progressive central nervous system metastases in responder patients for outside central nervous system metastases on trastuzumab-based therapy--report of two cases of refractory breast cancer
    Riki Okita
    Departments of Surgery and Clinical Research, National Shikoku Cancer Center Hospital, Ehime, Japan
    Hiroshima J Med Sci 54:35-8. 2005
    ..Additionally, repeated stereotactic radiosurgery as gammaknife combination therapy synchronously with systematic trastuzumab-based therapy was useful for the treatment of metastatic breast carcinoma...
  40. ncbi request reprint Immunohistochemical expression of hormone receptors and the histological characteristics of biochemically hormone receptor negative breast cancers
    Rieko Nishimura
    Department of Clinical Laboratory, National Hospital Organization Shikoku Cancer Center, Matsuyama, Ehime, Japan
    Breast Cancer 14:100-4. 2007
    ..The aim of this study is to examine the histological characteristics in immunohistochemically HR positive but biochemically HR negative breast cancers...
  41. ncbi request reprint [Local administration of adriamycin (ADM) for malignant pleural effusion and pericardiac effusion in breast cancer]
    Shinsuke Saisho
    Dept of Surgery, Clinical Research, National Shikoku Cancer Center
    Gan To Kagaku Ryoho 30:2063-8. 2003
    ..We conclude that local administration of ADM is useful for treatment, without severe toxicities, of malignant pleural effusion and pericardial effusion in breast cancer...
  42. ncbi request reprint [Toxicity of doxorubicin and cyclophosphamide (60 mg/600 mg/m2) in adjuvant chemotherapy for breast cancer]
    Yasuhiro Tsutani
    Dept of Surgery, National Hospital Organization Shikoku Cancer Center, Saitama Medical School
    Gan To Kagaku Ryoho 32:809-13. 2005
    ..9% vs 99.1%, p = 0.026). AC 60/600 is tolerated and feasible in adjuvant chemotherapy of breast cancer in Japanese patients from the viewpoint of toxicities...
  43. ncbi request reprint Occult breast carcinoma presenting with axillary lymph node metastases: follow-up of eleven patients
    Kinya Matsuoka
    Department of Cancer and Thoracic Surgery, Okayama University, Graduate School of Medicine and Dentistry, 2 5 1 Shikata cho, Okayama 700 8558, Japan
    Breast Cancer 10:330-4. 2003
    ..The methods of diagnosis and treatment of these patients are not established. We present our eleven treated cases of occult carcinoma and discuss the issues of evaluation and management...
  44. ncbi request reprint Measuring quality of life in patients with breast cancer: a systematic review of reliable and valid instruments available in Japan
    Takahiro Okamoto
    Department of Endocrine Surgery, Tokyo Women s Medical University, 8 1 Kawada cho, Shinjuku ku, Tokyo 162 8666, Japan
    Breast Cancer 10:204-13. 2003
    ..The purpose of this systematic review is to find reliable and valid instruments available in Japan, and to summarize their characteristics...
  45. ncbi request reprint Evidence-based risk factors for seroma formation in breast surgery
    Katsumasa Kuroi
    Division of Surgery and Breast Oncology, Nyuwakai Oikawa Hospital, 2 21 16 Hirao, Chuo Ku, Fukuoka 810 0014, Japan
    Jpn J Clin Oncol 36:197-206. 2006
    ..Seroma is a common problem in breast surgery. The aim of this systematic review was to identify risk factors for seroma formation...
  46. ncbi request reprint Phyllodes tumor of the breast: stromal overgrowth and histological classification are useful prognosis-predictive factors for local recurrence in patients with a positive surgical margin
    Naruto Taira
    Dentistry Pharmaceutical Sciences, Okayama University Graduate School of Medicine, 2 5 1 Shikata, Okayama 700 8558, Japan
    Jpn J Clin Oncol 37:730-6. 2007
    ..We reviewed the outcomes of excision of phyllodes tumors to investigate factors involved in local recurrence and to determine the indication for re-excision in stump-positive cases...
  47. ncbi request reprint Economic evaluation of the prevention and treatment of breast cancer--present status and open issues
    Hirohisa Imai
    Department of Epidemiology, National Institute of Public Health, Japan
    Breast Cancer 14:81-7. 2007
    ..The total medical expenditure continues to rise each year and some sort of evaluation from an objective and external viewpoint is required to provide the information with which to suppress this rise...
  48. ncbi request reprint Contrast-enhanced CT evaluation of clinically and mammographically occult multiple breast tumors in women with unilateral early breast cancer
    Naruto Taira
    Department of Breast and Endocrine Surgery, Okayama University Graduate School of Medicine, Dentistry, and Pharmaceutical Sciences, 2 5 1 Shikata cho, Okayama 700 8558, Japan
    Jpn J Clin Oncol 38:419-25. 2008
    ..Magnetic resonance imaging mammography is performed to determine the extent of lesions and to detect occult lesions, but preoperative diagnosis by breast computed tomography (CT) is less common...
  49. ncbi request reprint Current status of health outcome assessment of medical treatment in breast cancer
    Katsumasa Kuroi
    Division of Surgery, Breast Oncology, Nyuwakai Oikawa Hospital, Fukuoka, Japan
    Breast Cancer 14:74-80. 2007
    ..We also review the current status of HR-QOL assessment of medical treatment in breast cancer...
  50. ncbi request reprint [Retrospective evaluation of the safety of pamidronate administration at the dose of 90 mg/day/month in Japanese breast cancer patients with bone metastasis]
    Kenjiro Aogi
    Dept of Surgery, National Hospital Organization Shikoku Cancer Center
    Gan To Kagaku Ryoho 33:1247-51. 2006
    ..e., bone pain or elevation of tumor markers, were obtained in 91% of patients. As a conclusion, pamidronate administration at the dose of 90 mg/day/month was safe for Japanese breast cancer patients with bone metastasis...
  51. ncbi request reprint Relation between cancer cellularity and apparent diffusion coefficient values using diffusion-weighted magnetic resonance imaging in breast cancer
    Miho I Yoshikawa
    Department of Radiology, Tokai University School of Medicine, Tokai University Hachioji Hospital, 1838 Ishikawa, Hachioji, Tokyo 192 0032, Japan
    Radiat Med 26:222-6. 2008
    ..The purpose of this study was to examine the relation between cancer cellularity and the apparent diffusion coefficient (ADC) value using diffusion-weighted magnetic resonance imaging in breast cancer...
  52. ncbi request reprint A feasibility study of psychosocial group intervention for breast cancer patients with first recurrence
    Masami Chujo
    Graduate School of Health Sciences, Hiroshima University, 1 2 3 Kasumi, 734 8551 Minami ku, Hiroshima, Japan
    Support Care Cancer 13:503-14. 2005
    ..The objective of this study was to assess the feasibility of a psychosocial group intervention in Japanese women with first recurrence of breast cancer...
  53. ncbi request reprint Recent topics of health outcomes research in oncology
    Kojiro Shimozuma
    Department of Healthcare and Social Services, University of Marketing and Distribution Sciences, Kobe, Hyogo, Japan
    Breast Cancer 14:60-5. 2007
    ..Finally, we address the so-called 'response shift' which may affect the reliability of analysis results of QOL scores in longitudinal studies such as randomized clinical trials...
  54. ncbi request reprint Comparison of breast cancer detection by diffusion-weighted magnetic resonance imaging and mammography
    Miho I Yoshikawa
    Department of Diagnostic and Therapeutic Radiology, Ehime University Graduate School of Medicine, Shitsukawa, Toon, 791 0295, Japan
    Radiat Med 25:218-23. 2007
    ..Breast cancer-detecting ability of diffusion-weighted magnetic resonance imaging (DW-MRI) was investigated by comparing the breast cancer detection rates of DW-MRI and mammography (MMG)...
  55. ncbi request reprint Quality of Japanese health care evaluated as hospital functions
    Michikazu Ono
    Department of Health Science and Social Welfare School of Human Sciences Waseda University, Tokorozawa, Saitama, Japan
    Breast Cancer 14:88-91. 2007